Tag: hiking

Posts with tag: hiking

Latest Posts

Lilly Beats Q4 Earnings as GLP-1 Sales Surge

Eli Lilly's Q4 earnings beat estimates, sending shares up 2%. Revenue increased 45% to $13.5 billion, driven by GLP-1 drugs Mounjaro and Zepbound. Mounjaro alone brought in $11.5 billion, but missed Wall Street estimates. The company raised its 2025 guidance to $58-$61 billion.

Honeywell Divides into Three: Aerospace, Automation, and Advanced Materials

Honeywell (HON) Announces Separation Into Three Public Companies: Honeywell Automation, Honeywell Aerospace, and Advanced Materials

US vs. Europe: Why Filing Your Taxes Is a Headache Here

Compare taxes: Sweden's pre-filled returns vs. the US's complex, 13-hour process. See why the US tax code is so complicated and how it could be simplified.

Gold Demand Surges to New Records: Central Banks and Investors Seek Haven Amid Tariffs

Gold prices rise to record highs as central banks and investors seek safe haven amid escalating tariffs and geopolitical tensions, surpassing $2,877 per ounce.

Molina Healthcare Q4 2024 Earnings: Revenue Beat, EPS Miss

Molina Healthcare (NYSE:MOH) reports better-than-expected Q4 revenue of $10.5 billion, exceeding estimates by 1.9%. However, EPS of $4.44 falls below analysts' expectations, with a 19% miss. Guidance for 2025 includes revenue of $44 billion and EPS of $22.50, slightly beating and missing estimates, respectively.

Alpha and Omega Semiconductor Reports Q2 Loss, Shares Rise 17% YTD

Alpha and Omega Semiconductor Ltd. reports a loss of $6.6 million in its fiscal second quarter, with revenue of $173.2 million. For the current quarter, Alpha and Omega expects revenue in the range of $148 million to $168 million.

Align Technology Q4 CY2024 Earnings: Missed Revenue Guidance Weighs on Stock

Align Technology (NASDAQ: ALGN) reports inline Q4 results; revenue meets expectations but next quarter's guidance disappoints. Revenue up 4% year-over-year, non-GAAP EPS in line at $2.44 per share. Despite Q4 and 2024 results, revenue guidance for Q1 2025 falls below estimates. Find out more in our full research report.

Tariffs and Inflation: A Delicate Balancing Act for the Fed

Chicago Fed President Goolsbee warns against ignoring potential inflationary impact of tariffs, citing supply chain disruptions during COVID-19 pandemic.

Mattel (MAT) Soars 16.5% on Earnings Beat

Shares of toymaker Mattel (MAT) soared 16.5% after the company reported Q4 results that beat expectations. Revenue also exceeded estimates, and guidance outperformed Wall Street. Is it a buy?

Polestar Bets on US Manufacturing to Avoid Tariffs

Polestar feels the pain of tariffs on Chinese goods, but local production in the US and elsewhere immunizes the company from some of the impact.